Rotational Atherectomy Accounts for More Than 40% of the Atherectomy Prcodures Performed in China
Why Buy This Report
- First-ever syndicated report with robust insights from Interventional Cardiologists and Cardiologists
- Helps in understanding the current market scenario of the percutaneous coronary interventions in China
- Includes 100+ slide MS PowerPoint report and a MS Excel based 5-year market forecast model
- Valuable insights from from demand side of the market
- Keep up with the latest market trends and novel technologies
- Identify key players, local players and emerging players in the market
Table of Contents
RESEARCH PROCESS OVERVIEW- Detailed Research Methodology
- Desk Research and Quantitative Research
EXECUTIVE SUMMARY
PERCUTANEOUS CORONARY INTERVENTION (PCI) CHINA MARKET OVERVIEW
- Market Background - What is the scope of the research?
I - HEALTHCARE INFRASTRUCTURE (PROVIDER)
- Healthcare Delivery Structure
- Cardiac Catheterization and Chest Pain Centres (CPC) in China
- Chest Pain Centers (CPC) - Impact on Diagnosis and Treatment
- Healthcare Infrastructure - Digital Health Technology (DHT)
- Healthcare Infrastructure Challenges
- Percutaneous Coronary Intervention - Access Point
II - PROCEDURE INSIGHTS
- Procedure Split by Facility Type
- Procedure Split by Imaging Type
- Procedure Split by Device Type
- Procedure Split by Techniques
- Procedure Split by Intervention Type
- Procedure Growth Rates
III - BRAND PERCEPTION
- Brand Perception (Interventionalists)
- Best-in-Class Brands
IV - COMPETITIVE INTELLIGENCE
- CI Snapshot
- Key Competitor Activities
- Product portfolio
- Product Approval Overview
- Clinical Trials Overview
- Company Profile
- Product Approvals
- Clinical Trials
- Partnerships, M&A, Collaborations
- Key Market Activities
- Major Adverse Events
V - HEALTHCARE POLICY (PAYER)
- Medical Devices Regulatory Body
- Regulatory Approval Pathway
- Reimbursement landscape
- Disease Screening and Awareness Programs
- Health Insurance Coverage
- Digital Health Policy
VI - CLINICAL INTELLIGENCE (PHYSICIAN)
- Referral Pathway
- Treatment Overview
- Treatment Care Pathway
- Interventional Therapies
- Interventional Technology
- Healthcare Specialists (who are the Performing Physicians)
- Epidemiology
CONCLUSION
- FUTURE TRENDS
APPENDICES
Companies Mentioned
- Boston Scientific
- Medtronic
- Cordis
- B.Braun
- Shockwave Medical
- Philips
- Terumo
- BD/Bard
- Concept Medical
- OrbusNeich
- Microport Scientific
- JW Medical
- Genoss
- Shanghai Bio-heart biological Technology Co
- Elixir Medical Corporation
- Abbott
- Sinomed
- Kossel MedTech
- Biosensors International
- Lepu Medical
- LifeTech Scientific
